The Pharmaceutical Benefits Advisory Committee (PBAC) plays an important role in controlling the drugs that are available at subsidised prices under the Pharmaceutical Benefits Scheme (PBS). In brief, the Committee provides advice on whether a new drug is sufficiently cost-effective to merit its being added to the PBS. Listing is important to the drug manufacturers, because it has a beneficial ...

Spencer Phillips Hey and Aaron Kesselheim propose that informativeness-asserting scientific facts-rather than truthfulness ought to be the standard for regulating commercial speech about pharmaceuticals.

According to Gans & Stern (1999), firms engage in R&D spending, in part, in order to improve their bargaining position as buyers in the market for technology. We test this theory empirically with data from the pharmaceutical industry. We develop and estimate a structural model of R&D spending and licensing. We find that R&D spending does improve the bargaining position of licensees; although, t...

The subcutaneous insulin drug therapy, vial and syringe method is burdenful and time consuming. Another question to design an alternative way to deliver insulin by replaces injectable insulin to move comfortable dosage form. Consequently more acceptable at least effective insulin delivery has been developed over past years. This review examines some of many attempts made to developed alternativ...